Fatty Acid & Lipid Biosynthesis: New Pathway Found
Researchers pinpoint a groundbreaking mechanism in fatty acid synthesis regulation,presenting potential breakthroughs for metabolic disorder treatments. Their findings reveal that the enzyme RHBDL4 plays a key role in the cleavage of SREBP-1c,confirming its regulation by different types of fatty acids. This new pathway, explored through experimentation, shows promise for managing diseases stemming from irregular lipid metabolism. Saturated fatty acids activate the cleavage process, while polyunsaturated fatty acids deactivate it, demonstrating the pathway’s dynamic control. This novel discovery, highlighted by researchers, could lead to new therapeutic strategies targeting conditions like fatty liver disease. For more breaking biomedical news, visit News Directory 3. Discover what’s next as scientists translate these findings into advanced therapies.
New Pathway discovered for Fatty Acid Synthesis Regulation
Updated June 15, 2025
A team of researchers has identified a novel mechanism regulating fatty acid synthesis, a process vital for energy storage and cellular function. The study focuses on SREBP-1c,a protein that activates fatty acid synthesis,and its regulation by different types of fatty acids.
The research elucidated a new cleavage mechanism of SREBP-1c, confirming its regulation by fatty acids. The cleavage occurs in the endoplasmic reticulum (ER), where the rhomboid protease RHBDL4 acts as a key enzyme. Saturated fatty acids activate this cleavage, while polyunsaturated fatty acids deactivate it, suggesting RHBDL4’s activity is modulated by the type of fatty acid present.
The team also discovered that the VCP complex extracts the cleaved SREBP-1c protein from the ER. In experiments with mice lacking the RHBDL4 gene and fed a high-fat, high-cholesterol diet, SREBP-1c cleavage was suppressed. This suppression inhibited the expression of genes involved in fatty acid synthesis, polyunsaturated fatty acid synthesis and uptake, and lipoprotein secretion, ultimately improving fatty liver pathophysiology.
The newly uncovered RHBDL4-SREBP-1c pathway represents a lipid homeostasis mechanism regulated by fatty acids. Researchers believe this finding could lead to new therapeutic strategies for metabolic disorders and lifestyle-related diseases resulting from abnormal lipid metabolism.
What’s next
Further research will focus on translating these findings into targeted therapies for conditions like fatty liver disease and other metabolic disorders, potentially offering new hope for patients struggling with these conditions.